Lot of change after Novartis acquisition - werkgeversreview Senior Scientist II bij Alcon

3,0
19 jul 2013
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Other employees and great benefits.

Minpunten

Research group has changed for the worse since Novartis acquired Alcon. Not a great place to work any more.

Ontdek andere reviews over Alcon

5,0
21 mei 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Benefits, Work Life balance and culture

Minpunten

Slow product development cycles and consequently growth

3,0
10 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

The company has lots of perks and benefits and competitive compensation.

Minpunten

The culture has suffered significantly and there is a lack of support and commitment to the procurement function. The current morale is low with most people strategizing an exit plan.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle